Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
81 results
  1. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    resource.nlm.nih.gov/101723925
    ... be severe across all therapies, including myelodysplastic syndrome/acute ... are reported by regimen in Table 4.8. Note that these data are presented ...
  2. Late Effects of Treatment for Childhood Cancer (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65832
    ... related myelodysplastic syndrome (t-MDS) and therapy-related acute myeloid leukemia (t-AML). Therapy-related solid SNs. Therapy-Related ... related myelodysplastic syndrome (t-MDS) and therapy-related acute myeloid leukemia (t-AML) has been reported after treatment of ...
  3. Fanconi Anemia - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1401
    ... initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – ... changes and risk of development of myelodysplastic syndrome—acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet. ...
  4. Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®) - PDQ Cancer Information Summaries - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK223164
    ... a diverse range of patients, including patients with acute myeloid leukemia [ 8 ] or those who are considering allogeneic stem ... and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia 18 (4): 809- ...
  5. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... Myeloid, Accelerated Phase Leukemia, Myeloid, Chronic-Phase Leukemia, Myeloid, Acute Leukemia, Basophilic, Acute Leukemia, Eosinophilic, Acute Leukemia, Erythroblastic, Acute ...
  6. pdf2015 National Library of Medicine Informatics Conference Agenda Book 
    https://www.nlm.nih.gov/..._Informatics_Training_Conference_Book.pdf
    ... University of Texas MD Anderson Cancer Center Abstract: Acute Myeloid Leukemia (AML) is a very potent form of cancer ...
  7. Alphabetical List of Unprocessed Collections, 1997-2023 - Archives and Modern Manuscripts 
    https://www.nlm.nih.gov/hmd/manuscripts/accessions.html
    ... work at NCI. Died June 18, 2013 from acute myeloid leukemia. Principal investigator in NCI's Laboratory of Cell Biology ...
  8. NLM Digital Collections - Hematologic malignancies : regulatory considerations for use of minimal residual disease in ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2020
    resource.nlm.nih.gov/101760029
    ... an efficacy claim may change. 427 428 B. Acute Myeloid Leukemia 429 430 The molecular heterogeneity of AML poses ... 645 646 ALL acute lymphoblastic leukemia 647 AML acute myeloid leukemia 648 APL acute promyelocytic leukemia 649 ASO-PCR ...
  9. pdfNational Library of Medicine - Programs and Services, Fiscal Year FY2009 
    https://www.nlm.nih.gov/ocpl/anreports/fy2009.pdf
    ... Disease, Bone Fragility, Glaucoma, Breast Cancer, Pancreatic Cancer, Acute Myeloid Leukemia, and several updates to the Framingham Heart Study. ...
  10. Genetics of Breast and Gynecologic Cancers (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65767
    ... is 10% to 30% for hematologic malignancies (primarily acute myeloid leukemia) and 25% to 30% for nonhematologic malignancies (solid ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · next · last